Citation 41554

LOTZ-WINTER,H:. (1990). ON THE PHARMACOLOGY OF BROMELAIN: AND UPDATE WITH SPECIAL REGARD TO ANIMAL STUDIES ON DOSE-DEPENDENT EFFECTS.. 56(3)

Citation Details

Title	ON THE PHARMACOLOGY OF BROMELAIN: AND UPDATE WITH SPECIAL REGARD TO ANIMAL STUDIES ON DOSE-DEPENDENT EFFECTS.
Authors	LOTZ-WINTER,H:
Year	1990
Volume	56
Issue	3

Summary

Year: 1990

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTITHROMBIN TIME INCREASED	PHARMACOLOGY OF COMPOUND - IN VIVO	BROMELAIN	ACTIVE
2	PROTHROMBIN TIME INCREASED	PHARMACOLOGY OF COMPOUND - IN VIVO	BROMELAIN	ACTIVE
3	PLASMIN ACTIVITY INCREASE	PHARMACOLOGY OF COMPOUND - IN VIVO	BROMELAIN	ACTIVE
4	FIBRINOGEN LEVEL DECREASED	PHARMACOLOGY OF COMPOUND - IN VIVO	BROMELAIN	ACTIVE
5	FACTOR X LEVEL DECREASED	PHARMACOLOGY OF COMPOUND - IN VIVO	BROMELAIN	ACTIVE
6	PROTHROMBIN LEVEL DECREASED	PHARMACOLOGY OF COMPOUND - IN VIVO	BROMELAIN	ACTIVE
7	PROTHROMBIN TIME INCREASED	PHARMACOLOGY OF COMPOUND - IN VIVO	BROMELAIN	ACTIVE
8	FIBRINOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	BROMELAIN	ACTIVE
9	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	BROMELAIN	ACTIVE
10	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	BROMELAIN	ACTIVE
11	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	BROMELAIN	INACTIVE
12	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	BROMELAIN	ACTIVE
13	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	BROMELAIN	ACTIVE
14	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	BROMELAIN	ACTIVE
15	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	BROMELAIN	ACTIVE
16	PHARMACOKINETIC ALTERATION	PHARMACOLOGY OF COMPOUND - IN VIVO	BROMELAIN	ACTIVE
17	PHARMACOKINETIC ALTERATION	PHARMACOLOGY OF COMPOUND - IN VIVO	BROMELAIN	ACTIVE
18	PHARMACOKINETIC ALTERATION	PHARMACOLOGY OF COMPOUND - IN VIVO	BROMELAIN	ACTIVE
19	PHARMACOKINETIC ALTERATION	PHARMACOLOGY OF COMPOUND - IN VIVO	BROMELAIN	ACTIVE
20	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BROMELAIN	ACTIVE
21	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BROMELAIN	ACTIVE
22	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BROMELAIN	ACTIVE
23	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BROMELAIN	ACTIVE
24	CELL DIFFERENTIATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	BROMELAIN	ACTIVE
25	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	BROMELAIN	.
26	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	BROMELAIN	.
27	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	BROMELAIN	.
28	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	BROMELAIN	.
29	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	BROMELAIN	.
30	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	BROMELAIN	.

Citation 41554

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1